Infectious Diseases (except HIV/AIDS)

  1. Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

    1. Emily C Somers
    2. Gregory A Eschenauer
    3. Jonathan P Troost
    4. Jonathan L Golob
    5. Tejal N Gandhi
    6. Lu Wang
    7. Nina Zhou
    8. Lindsay A Petty
    9. Ji Hoon Baang
    10. Nicholas O Dillman
    11. David Frame
    12. Kevin S Gregg
    13. Dan R Kaul
    14. Jerod Nagel
    15. Twisha S Patel
    16. Shiwei Zhou
    17. Adam S Lauring
    18. David A Hanauer
    19. Emily Martin
    20. Pratima Sharma
    21. Christopher M Fung
    22. Jason M Pogue

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Characterizing and Forecasting Emergency Department Visits Related to COVID-19 Using Chief Complaints and Discharge Diagnoses

    1. Phillip Koshute
    2. Rekha Holtry
    3. Richard Wojcik
    4. Wayne Loschen
    5. Sheri Lewis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Cytokine biomarkers of COVID-19

    1. Hai-Jun Deng
    2. Quan-Xin Long
    3. Bei-Zhong Liu
    4. Ji-Hua Ren
    5. Pu Liao
    6. Jing-Fu Qiu
    7. Xiao-Jun Tang
    8. Yong Zhang
    9. Ni Tang
    10. Yin-Yin Xu
    11. Zhan Mo
    12. Juan Chen
    13. Jie-Li Hu
    14. Ai-Long Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Evaluating the impact of stay-at-home orders on the time to reach the peak burden of Covid-19 cases and deaths: does timing matter?

    1. Alexandra Medline
    2. Lamar Hayes
    3. Katia Valdez
    4. Ami Hayashi
    5. Farnoosh Vahedi
    6. Will Capell
    7. Jake Sonnenberg
    8. Zoe Glick
    9. Jeffrey D. Klausner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Clinical trial protocols of repurposed prophylaxis for COVID-19: A review

    1. E. Sallard
    2. D. Belhadi
    3. F.-X. Lescure
    4. Y. Yazdanpanah
    5. N. Peiffer-Smadja

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

    1. Shoya Iwanami
    2. Keisuke Ejima
    3. Kwang Su Kim
    4. Koji Noshita
    5. Yasuhisa Fujita
    6. Taiga Miyazaki
    7. Shigeru Kohno
    8. Yoshitsugu Miyazaki
    9. Shimpei Morimoto
    10. Shinji Nakaoka
    11. Yoshiki Koizumi
    12. Yusuke Asai
    13. Kazuyuki Aihara
    14. Koichi Watashi
    15. Robin N. Thompson
    16. Kenji Shibuya
    17. Katsuhito Fujiu
    18. Alan S. Perelson
    19. Shingo Iwami
    20. Takaji Wakita

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study

    1. Chao Cao
    2. Li He
    3. Jingping Ma
    4. Meiping Chen
    5. Yiting Li
    6. Qingwen Jiang
    7. Shiyu Wu
    8. Lili Yu
    9. Weina Huang
    10. Guoqing Qian
    11. Chuanbing Zhu
    12. Jinguo Chu
    13. Xiaomin Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Statistical methods for estimating cure fraction of COVID-19 patients in India

    1. E.P. Sreedevi
    2. P.G. Sankaran

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Uncertainty quantification in epidemiological models for the COVID-19 pandemic

    1. Leila Taghizadeh
    2. Ahmad Karimi
    3. Clemens Heitzinger

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Impact of social media on knowledge dissemination between physicians during COVID-19 virus outbreak: A cross sectional survey

    1. Aliae AR Mohamed-Hussein
    2. Nahed A Makhlouf
    3. Heba A Yassa
    4. Hoda A Makhlouf

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 53 of 716 Next